亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台，協助業界發掘知識產權貿易商機，並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權，或是製造商需要購買技術以提高操作效能，又或是知識產權配套服務供應商，你將會從本網站發掘到有用的知識產權貿易資訊。

返回搜索結果

Pancreatic Differentiation Process

技術優勢: This discovery offers the potential for scaled generation of functional insulin-producing cells in vitro, with more accurate maturation of the beta-cells.

詳細技術說明: UC San Diego researchers have developed a patent-pending process for cellular pancreatic differentiation, resulting in improved differentiation and maturation of hESCs to pancreatic beta cells. This discovery offers the potential for scaled generation of functional insulin-producing cells in vitro, with more accurate maturation of the beta-cells. As such, this patent-pending technology has the potential for utility in underpinning Islet transplantation as a practically feasible therapy for diabetes.

*Abstract: Diabetes is an autoimmune disease in which the immune system attacks and destroys the insulin-producing beta cells in the pancreas. Islet transplantation is a suitable therapy for diabetes, but the scarceness of islet donors makes this approach practically impossible in a higher scale. Promising alternative cell sources for treating diabetes comes from human embryonic stem cells (hESCs), and numerous groups have generated functional insulin-producing cells in vitro using stepwise differentiation protocols that mimic pancreatic development, including from diabetic patients. However, the limited transcriptomic data on these cells indicate that there remain marked differences between the most mature hESC-derived cells and primary human adult beta cells. Therefore, improvements in methodologies for proper maturation of beta-cells in vitro continues to be an intense area of research.

*Principal Investigation: Name: Louise Laurent
Department:

Name: Sergio Mora-Castilla
Department:

Name: Thomas Touboul
Department:

欲了解更多信息，請點擊這裡